Xometry (NASDAQ:XMTR – Free Report) had its price target lifted by The Goldman Sachs Group from $24.00 to $28.00 in a research note published on Wednesday, Benzinga reports. The brokerage currently has a buy rating on the stock.
A number of other research analysts have also recently weighed in on the stock. Royal Bank of Canada lifted their target price on shares of Xometry from $23.00 to $27.00 and gave the company a “sector perform” rating in a research note on Wednesday. Craig Hallum upped their price objective on Xometry from $20.00 to $30.00 and gave the stock a “buy” rating in a research note on Wednesday. Cantor Fitzgerald reissued an “underweight” rating and set a $12.00 target price on shares of Xometry in a research note on Wednesday. Finally, JMP Securities lifted their price objective on shares of Xometry from $27.00 to $32.00 and gave the company a “market outperform” rating in a research report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $26.29.
Check Out Our Latest Stock Report on Xometry
Xometry Stock Up 18.5 %
Xometry (NASDAQ:XMTR – Get Free Report) last announced its earnings results on Tuesday, November 5th. The company reported ($0.12) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.21) by $0.09. Xometry had a negative net margin of 10.53% and a negative return on equity of 10.75%. The company had revenue of $141.70 million during the quarter, compared to analyst estimates of $137.17 million. As a group, analysts forecast that Xometry will post -0.81 earnings per share for the current year.
Insiders Place Their Bets
In other Xometry news, CTO Matthew Leibel sold 3,400 shares of the stock in a transaction on Friday, September 13th. The shares were sold at an average price of $18.45, for a total transaction of $62,730.00. Following the completion of the transaction, the chief technology officer now owns 82,918 shares in the company, valued at $1,529,837.10. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 16.79% of the company’s stock.
Hedge Funds Weigh In On Xometry
A number of institutional investors and hedge funds have recently modified their holdings of XMTR. nVerses Capital LLC bought a new position in Xometry during the second quarter valued at $38,000. ProShare Advisors LLC purchased a new stake in Xometry in the 2nd quarter worth about $53,000. Point72 Asset Management L.P. bought a new stake in Xometry in the second quarter worth about $55,000. US Bancorp DE boosted its position in shares of Xometry by 57.7% during the third quarter. US Bancorp DE now owns 5,570 shares of the company’s stock valued at $102,000 after buying an additional 2,037 shares during the period. Finally, Susquehanna Fundamental Investments LLC bought a new position in shares of Xometry during the second quarter valued at approximately $129,000. Hedge funds and other institutional investors own 97.31% of the company’s stock.
About Xometry
Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.
Read More
- Five stocks we like better than Xometry
- The Basics of Support and Resistance
- MGM vs. Las Vegas Sands: Which Casino Stock Is the Better Bet?
- How to Calculate Retirement Income: MarketBeat’s Calculator
- What a Trump Win Looks Like for the Market Now and Into 2025
- Top Biotech Stocks: Exploring Innovation Opportunities
- Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop
Receive News & Ratings for Xometry Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xometry and related companies with MarketBeat.com's FREE daily email newsletter.